M.K. Exim board meetings: key dates, results, 2025

What M.K. Exim told BSE and why it matters

M.K. Exim (India) Ltd has made a series of stock exchange disclosures to BSE around board meetings held through 2025 and early 2026. These filings largely relate to the approval of quarterly and annual financial results, along with routine governance actions such as key managerial appointments and board performance reviews. For investors, such updates matter because they signal when financial results are considered and approved, and when trading restrictions apply for insiders.

The disclosures cite SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, including Regulation 29 (advance intimation of board meetings) and Regulation 30 (outcomes and material disclosures). The company also referred to publication requirements under Regulation 47, and trading window closure under SEBI (Prohibition of Insider Trading) Regulations, 2015.

Board meeting on 5 November 2025: Q2 and H1 FY26 results

In its notice, M.K. Exim (India) said its Board of Directors meeting was scheduled for Wednesday, 5 November 2025. The stated agenda included considering and approving un-audited standalone financial results along with a limited review report from the statutory auditors for the quarter and half-year ended 30 September 2025.

The company later disclosed the outcome of that meeting held on the same day. It said the board considered and approved the un-audited standalone financial results for the quarter and half-year ended 30 September 2025, along with the limited review report. It also noted that the results, along with a QR code, would be published in newspapers as per Regulation 47(1)(b), and would be made available on the company’s website (www.mkexim.com).

The company also disclosed the meeting time, stating that it commenced at 03:00 P.M. and concluded at 03:30 P.M.

Trading window closure linked to results announcement

For the November 2025 results cycle, the company stated that the trading window for dealing in the securities of the company would remain closed for all designated persons and their immediate relatives, promoters and promoter group entities. The closure was stated to continue until 48 hours after the declaration of the relevant un-audited standalone financial results.

Such trading window closures are standard compliance steps under insider trading regulations, aimed at preventing trading while unpublished price-sensitive information is being prepared and reviewed. Investors typically see these as procedural disclosures, but they can help track the results calendar and governance compliance.

Board meeting on 5 August 2025: Q1 FY26 results

M.K. Exim (India) also informed BSE that a board meeting was scheduled on Tuesday, 5 August 2025 to consider and approve un-audited standalone financial results for the quarter ended 30 June 2025, along with the limited review report from statutory auditors. The company later disclosed that the board considered and approved the same set of results and the limited review report.

It stated that the results would be published in newspapers under Regulation 47(1)(b) and made available on the company’s website. The company also disclosed the meeting time, stating it commenced at 02:00 P.M. and concluded at 03:00 P.M.

Board meeting on 18 August 2025: agenda-based approvals

Separately, the company intimated that another board meeting was scheduled on Monday, 18 August 2025 at Unit No. 235, 5B-Sanjay Building, Mittal Industrial Estate, Mumbai, Maharashtra - 400059. The company said this meeting would consider and approve agenda items “as set out in attachment.”

In the outcome filing for the same date, the company stated the board “considered and approved as attached alongwith.” The disclosure does not provide the detailed agenda contents in the text provided, so the specific items cannot be summarised beyond what was stated.

Board meeting on 27 May 2025: audited annual results and a nodal officer

For the financial year-end cycle, M.K. Exim (India) informed BSE that a board meeting was scheduled on Tuesday, 27 May 2025. The agenda included adopting audited standalone and consolidated financial results for the quarter and financial year ended 31 March 2025, along with the auditors’ report, pursuant to Regulation 33 of SEBI (LODR) Regulations.

The same notice also included a proposal to appoint Mrs. Bhavna Giamalani as the Nodal Officer under the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016. The company later disclosed that the outcome of the board meeting held on 27 May 2025 was attached, but those attachment details are not included in the provided text.

Board meeting on 11 April 2025: company secretary and internal auditor appointments

In another disclosure, the company said a board meeting was scheduled on Friday, 11 April 2025 to consider appointments. The stated agenda included appointing Mrs. Bhavna Giamalani (M. No. A56103) as Company Secretary and Compliance Officer, and appointing R. Attar & Company, Chartered Accountants, Jaipur (FRN: 007180C) as internal auditors for FY 2025-26.

In the outcome disclosure, M.K. Exim (India) stated that the board appointed Mrs. Bhavna Giamalani as Company Secretary and Compliance Officer with effect from 11 April 2025. It also stated the appointment of M/s R. Attar & Company as internal auditors for FY 2025-26. The company disclosed the meeting time as commencing at 03:30 P.M. and concluding at 04:00 P.M.

Independent directors’ meeting on 21 March 2025

The company disclosed that independent directors met separately on Friday, 21 March 2025. As per the disclosure, they reviewed the performance of non-independent directors and the board as a whole, reviewed the performance of the chairperson considering views of executive and non-executive directors, and assessed the quality, quantity and timeliness of information flow between management and the board.

This kind of separate meeting is a governance practice aligned with expectations for independent directors, particularly around performance evaluation and board effectiveness.

Results approval on 3 February 2026: Q3 FY26 update

The provided text also includes a disclosure stating that the board, in its meeting held on Tuesday, 3 February 2026, considered and approved un-audited standalone financial results for the quarter and nine months ended 31 December 2025, along with the limited review report by the statutory auditors. The company said the results would be published in newspapers under Regulation 47(1)(b) and also made available on www.mkexim.com.

The disclosure also included meeting timings: the meeting commenced at 04:30 P.M. and concluded at 05:00 P.M.

AGM record date: 18 September 2025

Among the announcements referenced is an intimation that the company fixed Thursday, 18 September 2025 as the cut-off date and record date for the purpose of the 33rd Annual General Meeting for FY 2024-25.

Record dates and cut-off dates are relevant for determining shareholder eligibility for voting and other AGM-related entitlements as defined by the company in its AGM process.

Key dates at a glance

What investors can take away

The pattern of disclosures indicates a regular cadence of results-related board meetings, with outcomes filed to BSE after approvals. The company has consistently linked results approvals with statutory auditor limited review reports for un-audited periods, and with auditor reports for audited year-end results.

The filings also reflect routine governance processes, including the appointment of a company secretary and compliance officer, appointment of internal auditors for FY 2025-26, and independent directors’ performance review. Where the company refers to attachments for detailed agenda items or outcome documents, those specifics are not present in the provided text, so any further interpretation would require reading the attached exchange filings.

Conclusion

Across 2025 and early 2026, M.K. Exim (India) used BSE filings to announce board meeting schedules and outcomes mainly focused on financial results approvals and governance actions. The next level of detail for investors would come from the published financial results and the attached agenda and outcome documents referenced in the disclosures, as well as the company’s website updates cited in its filings.